tv3326 has been researched along with vilazodone in 1 studies
| Studies (tv3326) | Trials (tv3326) | Recent Studies (post-2010) (tv3326) | Studies (vilazodone) | Trials (vilazodone) | Recent Studies (post-2010) (vilazodone) |
|---|---|---|---|---|---|
| 15 | 0 | 11 | 15 | 0 | 11 |
| Protein | Taxonomy | tv3326 (IC50) | vilazodone (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.0002 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 2 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 6 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 1.51 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 6 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 6 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.071 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0003 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.1581 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.98 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 5 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 4 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 3.4 | |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | 3 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0004 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0067 | |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | 3 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 1.98 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 1.98 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 4.3 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.666 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0003 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.295 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 5.575 | |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 0.252 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 4.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A; Mishra, P; Panda, G | 1 |
1 review(s) available for tv3326 and vilazodone
| Article | Year |
|---|---|
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Ligands; Neuroprotective Agents | 2019 |